Presentations March 11, 2024 Ventyx Virtual Investor Event February 22, 2024 VTX002 Phase 2 UC Oral Presentation ECCO 2024 November 6, 2023 VTX958 Phase 2 Plaque Psoriasis Results October 9, 2023 VTX002 Phase 2 Ulcerative Colitis Results January 26, 2023 Ventyx R&D Day Presentation August 15, 2022 VTX958 Phase 1 Topline Results